Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in Arterioscler Thromb Vasc Biol Retrieve available abstracts of 14 articles: HTML format

Single Articles

November 2022
1. GOLLEDGE J
   New Genomic Techniques Provide Novel Insights Into Ascending Aortic Aneurysm Pathology.
   Arterioscler Thromb Vasc Biol. 2022;42:1375-1377.
   PubMed    
   
   
   July 2022
2. TANIGUCHI R, Ohashi Y, Lee JS, Hu H, et al
   Endothelial Cell TGF-beta (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency.
   Arterioscler Thromb Vasc Biol. 2022;42:868-883.
   PubMed     Abstract available
   
   
   June 2022
3. PAVASINI R, Campo G
   Ticagrelor and Endothelial Function: An Effect That Persists Far From the Acute Phase and in Monotherapy.
   Arterioscler Thromb Vasc Biol. 2022;42:799-801.
   PubMed    
   
   
   May 2022
4. DACANO JL, Aikawa M, Singh SA
   Promise of a Novel Bedside-to-Bench Paradigm: Can Percutaneous Coronary Intervention Proteomics Balloon Into Clinical Practice?
   Arterioscler Thromb Vasc Biol. 2022 May 26:101161ATVBAHA122317802.
   PubMed    
   
   
   April 2022
5. LORENTZEN LG, Hansen GM, Iversen KK, Bundgaard H, et al
   Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons.
   Arterioscler Thromb Vasc Biol. 2022 Apr 21:101161ATVBAHA122317491.
   PubMed     Abstract available
   
   
   
6. TAM CF, Chan YH, Wong YK, Li Z, et al
   Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome.
   Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317513.
   PubMed     Abstract available
   
   
   March 2022
7. CHOXI R, Kapoor K, Mackman N, Jovin IS, et al
   Direct Oral Anticoagulants and Coronary Artery Disease.
   Arterioscler Thromb Vasc Biol. 2022 Mar 17:ATVBAHA121317171.
   PubMed     Abstract available
   
   
   December 2021
8. MATSUBARA ( ) Y, Gonzalez L, Kiwan G, Liu ( ) J, et al
   PD-L1 (Programmed Death Ligand 1) Regulates T-Cell Differentiation to Control Adaptive Venous Remodeling.
   Arterioscler Thromb Vasc Biol. 2021;41:2909-2922.
   PubMed     Abstract available
   
   
   August 2021
9. KRALER S, Libby P, Evans PC, Akhmedov A, et al
   Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs.
   Arterioscler Thromb Vasc Biol. 2021;41:2237-2251.
   PubMed     Abstract available
   
   
   July 2021
10. ALKARITHI G, Duval C, Shi Y, Macrae FL, et al
    Thrombus Structural Composition in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2021 Jul 15:ATVBAHA120315754.
    PubMed     Abstract available
    
    
    
11. MADDER RD, Kubo T, Ino Y, Kameyama T, et al
    Target Lesion Lipid Content Detected by Near-Infrared Spectroscopy After Stenting and the Risk of Subsequent Target Lesion Failure.
    Arterioscler Thromb Vasc Biol. 2021;41:2181-2189.
    PubMed     Abstract available
    
    
    June 2021
12. CORNELISSEN A, Guo L, Fernandez R, Kelly MC, et al
    Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
    Arterioscler Thromb Vasc Biol. 2021 Jun 24:ATVBAHA121316472.
    PubMed     Abstract available
    
    
    
13. GEORGAKIS MK, van der Laan SW, Asare Y, Mekke JM, et al
    Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability.
    Arterioscler Thromb Vasc Biol. 2021;41:2038-2048.
    PubMed     Abstract available
    
    
    March 2021
14. FLETCHER EK, Wang Y, Flynn LK, Turner SE, et al
    Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2021 Mar 25:ATVBAHA120315837.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: